510(k) K213938
K213938 is an FDA 510(k) premarket notification submitted by Ge Healthcare Japan Corporation for the device "Revolution Ascend". The FDA issued a decision of Substantially Equivalent on February 4, 2022. The device falls under product code JAK (System, X-Ray, Tomography, Computed), a Class II device regulated under 21 CFR 892.1750. Ge Healthcare Japan Corporation has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 4, 2022
- Date Received
- December 16, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, X-Ray, Tomography, Computed
- Device Class
- Class II
- Regulation Number
- 892.1750
- Review Panel
- RA
- Submission Type